Table 4 Comparison regarding patient demographics, bronchoscopic characteristics and pre-procedure maximum respiratory pressures among different midazolam dose groups
From: Flexible bronchoscopy may decrease respiratory muscle strength: premedicational midazolam in focus
Group A (n: 34) | Group B (n: 66) | Group C (n: 40) | p | |
|---|---|---|---|---|
Male gender, n (%) | 24 (70.6) | 53 (80.3) | 25 (62.5) | NS |
Age | 58.9 ±11.8 | 55.9 ±14.5 | 60.9 ±12.8 | NS |
Patients with COPD, n (%) | 14 (41.2) | 21 (31.8) | 9 (22.5) | NS |
Smoking pack years | 27.6 ±11.6 | 38.9 ±18.9 | 36.9 ±21.9 | NS |
Duration of bronchoscopy (min) | 15.5 ±5.9 | 15.6 ±5.4 | 16.9 ±7.3 | NS |
Complications | ||||
Tachycardia | 19 | 31 | 12 | NS |
Bradycardia | 1 | 1 | 0 | NS |
Hypotension | 0 | 1 | 0 | NS |
Hypertension | 5 | 5 | 3 | NS |
Desaturation | 2 | 1 | 1 | NS |
Patient comfort | 76.2 ±17.4 | 74.4 ±17.4 | 88.1 ±12.5* | <0.001 |
MIP 1 (cmH 2 O) | 80.5 ±25.2 | 69.3 ±23.1 | 75.9 ±24.9 | NS |
MEP 1 | 109.4 ±27.6 | 93.6 ±30.1 | 102.1 ±28.9 | NS |